NVO
Novo Nordisk A/SClose $45.07EOD onlyThis page reflects NVO options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Historical consensus-supported lens with full content, report chain context, and metric rail.
Outlook
Bearish with a strong gravitational pull to the $35 gamma flip level. Confidence: 8/10. The regime is clearly defined by negative GEX (-$2.2M) and bearish net premium flow (-$82.1M), indicating a trending environment. Spot is pinned at max pain for the nearest expiries, but the rising MP trend and structural put OI at $35 create a downside bias.
Conflicts: Spot at near-term max pain ($37) suggests a temporary pin, but structural levels and flow override.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-2.2M
DEX: +41.4M shares
Gamma flip: ~$35 (Approx — based on put OI concentration of 21,646)
NTM gamma: Dealers are net short gamma (GEX negative). A move **below $36** accelerates their delta-hedging sell flow. A move **above $37** would see them buy to cover, but the short gamma position is less sensitive to the upside.
IV Analysis
IV vs VIX: IV 53.4% is extremely elevated (no VIX given, but contextually very high), making premium selling attractive but tail risks significant.
Term structure: Steeply upward sloping near-term (40.4% 2d → 52.0% 38d), indicating high event risk priced into May (earnings 5/6). Kinks at 5/8 (52.0%) and 5/15 (51.3%) expirations.
Skew: Massive skew in far OTM puts ($65 strike IV 131%, $60 strike IV 74%) reflects expensive tail hedging. The ~12 vol-point drop from May to June (52% → 49%) offers a calendar spread opportunity for vol sellers.
Flow Analysis
Net premium: -$82.1M bearish; P/C Vol 1.50 (put dominance), P/C OI 0.74.
Directional prints: 1) $65P 4/17: Vol 10K vs OI 1,250 (8x), IV 131% — **interpretation**: Likely bought as a far OTM hedge or speculative put. 2) $36.50C 4/10: Vol 1,626 vs OI 235 (6.9x) — **interpretation**: Could be bought calls betting on a bounce to MP or sold covered calls; the bearish net premium context favors the latter. 3) $40P 4/2: Vol 2,682 vs OI 656 (4.1x), IV 107% — likely bought puts for near-term protection.
Unusual: $25C 9/18: Vol 2,352 vs OI 289 (8x), IV 71% — deep ITM call with high vol, likely a financed or diagonal trade component.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long Stock | Weak | N/A | Negative GEX and bearish flow suggest better entry lower, near $35 support. |
| Short Stock | Moderate-Strong | Entry near $37, target $35. | Near-term pin at max pain $37; stop above $38.72 (1w EM high). |
| Covered Call | Moderate | If long stock, sell $37.5 or $38 Call Apr-10 or Apr-17. | Stock drifts to $35, call premium insufficient to offset loss. |
| Cash-Secured Put / Put Spread | Moderate-Strong | Sell $35 Put Apr-17 (~45 DTE) or sell $36/$34 Put Spread Apr-17. | Break below $35 gamma flip leads to assignment/max loss. |
| Long Puts / Bear Put Spread | Strong | Buy $37/$35 Put Spread Apr-10 (10 DTE) or $36.5/$34 Put Spread Apr-17 (17 DTE). | Pin at $37; time decay in high IV environment. |
| Iron Condor | Moderate-Weak | Given GEX negative and VIX contextually high (>25), edge is weak. $35/$33P x $38/$40C Apr-17. | Trending regime breaks range; high IV increases wing cost. |
| Calendar/Diagonal | Moderate | **Reverse Calendar (Sell high IV, Buy lower IV)**: Sell $35 Put May-8 (IV 52%), Buy $35 Put Jun-18 (IV 49%). Direction: Bearish/Neutral. | Earnings event in short leg (May-8) creates pin risk. |
| PMCC / LEAPS Diagonal | Moderate | Buy Jan-27 $25 Call (ITM, low time decay), sell Apr-17 $37 or $38 Call against it. Direction: Bullish with income. | Bearish regime pressures long LEAPS; short call may be challenged. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.